Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Abeona Therapeutics (ABEO)

Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 209,321
  • Shares Outstanding, K 40,963
  • Annual Sales, $ 3,500 K
  • Annual Income, $ -54,190 K
  • 60-Month Beta 1.59
  • Price/Sales 58.99
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade ABEO with:

Options Overview Details

View History
  • Implied Volatility 131.10% ( -178.48%)
  • Historical Volatility 48.84%
  • IV Percentile 69%
  • IV Rank 38.75%
  • IV High 309.58% on 07/19/24
  • IV Low 18.17% on 07/05/24
  • Put/Call Vol Ratio 2.63
  • Today's Volume 69
  • Volume Avg (30-Day) 291
  • Put/Call OI Ratio 0.30
  • Today's Open Interest 4,589
  • Open Int (30-Day) 4,266

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.33
  • Number of Estimates 4
  • High Estimate -0.26
  • Low Estimate -0.45
  • Prior Year -0.44
  • Growth Rate Est. (year over year) +25.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
4.04 +26.74%
on 06/27/24
5.70 -10.17%
on 07/15/24
+0.54 (+11.79%)
since 06/21/24
3-Month
3.05 +67.87%
on 04/25/24
5.70 -10.17%
on 07/15/24
-2.24 (-30.43%)
since 04/22/24
52-Week
2.83 +80.92%
on 08/08/23
9.01 -43.17%
on 03/06/24
+1.39 (+37.27%)
since 07/21/23

Most Recent Stories

More News
Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 5.11 (+1.17%)
Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 5.11 (+1.17%)
Abeona Therapeutics: Q2 Earnings Snapshot

Abeona Therapeutics: Q2 Earnings Snapshot

ABEO : 5.11 (+1.17%)
Abeona Therapeutics: Q1 Earnings Snapshot

Abeona Therapeutics: Q1 Earnings Snapshot

ABEO : 5.11 (+1.17%)
Three Small-Cap Biotech Stocks to Consider Now

This article looks at three small-cap biotech companies with stock prices that are making significant moves and have a bright outlook for 2023 

HARP : 23.01 (+0.09%)
HTGM : 0.4800 (-20.00%)
ABEO : 5.11 (+1.17%)
Abeona Therapeutics: Q3 Earnings Snapshot

Abeona Therapeutics: Q3 Earnings Snapshot

ABEO : 5.11 (+1.17%)
Abeona Therapeutics Reports Second Quarter 2022 Financial Results

Disposition of MPS programs allows Abeona to extend runway of current cash into 2Q 2023 Phase 3 VIITALâ„¢ study topline data expected in late-3Q/early-4Q...

ABEO : 5.11 (+1.17%)
Abeona Therapeutics Regains Compliance with Nasdaq Listing Requirements

NEW YORK and CLEVELAND, July 20, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced that it received notice from The Nasdaq...

ABEO : 5.11 (+1.17%)
Abeona Therapeutics to Present at the Jefferies Healthcare Conference

NEW YORK and CLEVELAND, June 06, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy,...

ABEO : 5.11 (+1.17%)
Abeona Therapeutics Granted Second 180-Day Period by Nasdaq to Regain Compliance with Minimum Bid Price Rule

NEW YORK and CLEVELAND, May 19, 2022 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in cell and gene therapy,...

ABEO : 5.11 (+1.17%)

Business Summary

Abeona Therapeutics, Inc. is engaged in developing and delivering gene therapy and plasma-based products for rare diseases. Abeona Therapeutics Inc., formerly known as PlasmaTech Biopharmaceuticals, Inc., is based in Dallas, United States.

See More

Key Turning Points

3rd Resistance Point 5.47
2nd Resistance Point 5.36
1st Resistance Point 5.24
Last Price 5.11
1st Support Level 5.01
2nd Support Level 4.90
3rd Support Level 4.78

See More

52-Week High 9.01
Fibonacci 61.8% 6.65
Fibonacci 50% 5.92
Fibonacci 38.2% 5.19
Last Price 5.11
52-Week Low 2.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar